Biofarm will invest 47 million lei in upgrading equipment and developing a new R&D center by 2025.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
Biofarm, a leading Romanian drug manufacturer, plans to invest 47 million lei in upgrading its production plant on Logofătul Tăutu Street and developing a new research and development center. The project aims to modernize equipment in order to improve the efficiency of manufacturing processes and better respond to market demands. CEO Cătălin Vicol emphasizes that this initiative is part of Biofarm's strategy to increase its presence on international markets.
Sources
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare. Bugetul de investiţii al Biofarm în 2025 este de 47 mil. lei (aproape 10 mil. euro), în creştere faţă de anul anterior, cand a fost de 31 mil. lei
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare
Latest News
16:12
Daniel Băluță presents the progress of the Apărătorii Patriei Overpass and the construction’s “eccentric pillars”
16:05
Alexandru Rogobete warns that ambulances could run out of money for fuel from October 1
15:54
Giorgia Meloni: Italy’s economy could grow by 1% in 2026 despite difficulties
15:43
A 50-year-old driver hit four cars parked in Sibiu and damaged a gas pipe
15:32
Vladimir Putin attributed the AfD’s record result to the mistakes and policies of Western countries
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
